Volume 93, Issue 3, Pages (March 2018)

Slides:



Advertisements
Similar presentations
Volume 62, Issue 6, Pages (December 2002)
Advertisements

Volume 66, Issue 4, Pages (October 2004)
Volume 81, Issue 2, Pages (January 2012)
Volume 82, Issue 7, Pages (October 2012)
Paraneoplastic glomerulopathies: New insights into an old entity
Hatem Elabd, Rushi Nayak, Tarek Rashid, M. Barry Stokes 
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use  Mei-Ling Blank, Lianne.
Volume 66, Issue 1, Pages (July 2004)
Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification 
Expression of the C-C chemokine receptor 5 in human kidney diseases1
Jean-Claude Davin, Ineke J. Ten Berge, Jan J. Weening 
Volume 91, Issue 2, Pages (February 2017)
Volume 74, Issue 1, Pages (July 2008)
Volume 82, Issue 7, Pages (October 2012)
Milk-Alkali Syndrome Mayo Clinic Proceedings
Volume 70, Issue 7, Pages (October 2006)
Volume 68, Issue 2, Pages (August 2005)
Hyun Soon Lee, Young Sook Kim  Kidney International 
Lithium-associated nephropathy in the renal allograft
Volume 80, Issue 10, Pages (November 2011)
C3 Glomerulonephritis Associated With Complement Factor B Mutation
Kumar Sharma, Ljiljana Paša-Tolić  Kidney International 
Tubular NF-κB and AP-1 activation in human proteinuric renal disease
Volume 93, Issue 1, (January 2018)
Volume 65, Issue 1, Pages (January 2004)
The spectrum of kidney biopsy findings in patients with morbid obesity
Postinfectious Glomerulonephritis
Iva Gunnarsson, MD, PhD  American Journal of Kidney Diseases 
Volume 71, Issue 6, Pages (March 2007)
Volume 78, Issue 5, Pages (September 2010)
Volume 88, Issue 4, Pages (October 2015)
Volume 95, Issue 3, Pages (March 2019)
Gas in a renal allograft: think beyond!
Volume 66, Issue 4, Pages (October 2004)
Synaptopodin expression in idiopathic nephrotic syndrome of childhood
Volume 95, Issue 3, Pages (March 2019)
Volume 70, Issue 8, Pages (October 2006)
Volume 76, Issue 5, Pages (September 2009)
Volume 61, Issue 1, Pages (January 2002)
HIV-related nephropathy: A South African perspective
No complement receptor 1 stumps on podocytes in human glomerulopathies
Volume 72, Issue 12, Pages (December 2007)
Volume 65, Issue 4, Pages (April 2004)
Immunofluorescence on pronase-digested paraffin sections: A valuable salvage technique for renal biopsies  S.H. Nasr, S.J. Galgano, G.S. Markowitz, M.B.
Immunohistochemical and serological evidence for the role of streptococcal proteinase in acute post-streptococcal glomerulonephritis  Gil A. Cu, Sergio.
Volume 92, Issue 4, (October 2017)
Volume 69, Issue 8, Pages (April 2006)
Mechanisms of tubulointerstitial injury in IgA nephropathy
Volume 71, Issue 4, Pages (February 2007)
Antiglomerular basement membrane disease with normal renal function
Volume 82, Issue 7, Pages (October 2012)
Volume 57, Issue 3, Pages (March 2000)
Class IV-S versus class IV-G lupus nephritis: Clinical and morphologic differences suggesting different pathogenesis  Gary S. Hill, Michel Delahousse,
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 69, Issue 10, Pages (May 2006)
Amylin deposition in the kidney of patients with diabetic nephropathy
Volume 73, Issue 5, Pages (March 2008)
Membranous nephropathy: recent travels and new roads ahead
Volume 63, Issue 6, Pages (June 2003)
Volume 80, Issue 9, Pages (November 2011)
Unmasking a unique glomerular lesion
Volume 55, Issue 5, Pages (May 1999)
Epidemiologic data of primary glomerular diseases in western France
Absolute renal biopsy diagnosis frequencies of the most common glomerular disease subtypes according to patient age category. Absolute renal biopsy diagnosis.
Volume 96, Issue 1, Pages 5-7 (July 2019)
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Direct immunofluorescence showing granular mesangial staining for IgA in the expanded mesangium of the biopsy of patient 4, who had underlying diabetic.
Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis  Eero O. Honkanen, Anna-Maija Teppo, Carola.
Relative renal biopsy diagnosis frequencies of the most common glomerular disease subtypes according to patient age category and typical mode of clinical.
Dysproteinemia and the Kidney: Core Curriculum 2019
Presentation transcript:

Volume 93, Issue 3, Pages 700-705 (March 2018) IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis  Hitoshi Suzuki, Junichi Yasutake, Yuko Makita, Yuki Tanbo, Kohei Yamasaki, Tadashi Sofue, Toshiki Kano, Yusuke Suzuki  Kidney International  Volume 93, Issue 3, Pages 700-705 (March 2018) DOI: 10.1016/j.kint.2017.10.019 Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 1 Glomerular deposition of galactose-deficient IgA1 in patients with IgA nephropathy (IgAN). Double staining with anti-IgA polyclonal antibody and KM55 monoclonal antibody was performed on biopsy specimens from 48 patients with IgAN. Five clinical cases are shown. Galactose-deficient IgA1 was clearly localized predominantly in the mesangium with IgA C3. (Bars = 100 μm; original magnification X200.) To optimize viewing of this image, please see the online version of this article at www.kidney-international.org. Kidney International 2018 93, 700-705DOI: (10.1016/j.kint.2017.10.019) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 2 KM55 mAb staining. (a) KM55 mAb staining in various types of glomerular diseases. Glomerular galactose-deficient IgA1 staining was negative in cases of hepatitis C virus–related nephropathy (HCV-RN), hepatic glomerulosclerosis, idiopathic membranous nephropathy (MN), secondary MN, acute poststreptococcal glomerulonephritis (APSGN), antineutrophil cytoplasmic antibody (ANCA)–related nephropathy, and minimal change nephrotic syndrome (MCNS).(b) KM55 mAb staining in lupus nephritis. Five cases of lupus nephritis are shown as examples. In all cases of lupus nephritis that were accompanied by glomerular IgA deposition, glomerular galactose-deficient IgA1 staining was negative. (c) KM55 mAb staining in IgA vasculitis with nephritis (IgA-VN). Five cases of IgA-VN are shown as examples. All cases of IgA-VN exhibited glomerular galactose-deficient IgA1 staining, mainly in the mesangial area, as seen in cases of IgA nephropathy (IgAN). (Bars = 100 μm; original magnification X200.) To optimize viewing of this image, please see the online version of this article at www.kidney-international.org. Kidney International 2018 93, 700-705DOI: (10.1016/j.kint.2017.10.019) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 2 KM55 mAb staining. (a) KM55 mAb staining in various types of glomerular diseases. Glomerular galactose-deficient IgA1 staining was negative in cases of hepatitis C virus–related nephropathy (HCV-RN), hepatic glomerulosclerosis, idiopathic membranous nephropathy (MN), secondary MN, acute poststreptococcal glomerulonephritis (APSGN), antineutrophil cytoplasmic antibody (ANCA)–related nephropathy, and minimal change nephrotic syndrome (MCNS).(b) KM55 mAb staining in lupus nephritis. Five cases of lupus nephritis are shown as examples. In all cases of lupus nephritis that were accompanied by glomerular IgA deposition, glomerular galactose-deficient IgA1 staining was negative. (c) KM55 mAb staining in IgA vasculitis with nephritis (IgA-VN). Five cases of IgA-VN are shown as examples. All cases of IgA-VN exhibited glomerular galactose-deficient IgA1 staining, mainly in the mesangial area, as seen in cases of IgA nephropathy (IgAN). (Bars = 100 μm; original magnification X200.) To optimize viewing of this image, please see the online version of this article at www.kidney-international.org. Kidney International 2018 93, 700-705DOI: (10.1016/j.kint.2017.10.019) Copyright © 2017 International Society of Nephrology Terms and Conditions